Dewpoint Therapeutics

Dewpoint Therapeutics

Biotechnology, 6 Tide St, Boston, Massachusetts, 02210, United States, 51-200 Employees

dewpointx.com

  • twitter
  • LinkedIn

phone no Phone Number: 61********

Who is DEWPOINT THERAPEUTICS

Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulate...

Read More

map
  • 6 Tide St, Boston, Massachusetts, 02210, United States Headquarters: 6 Tide St, Boston, Massachusetts, 02210, United States
  • 2018 Date Founded: 2018
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from DEWPOINT THERAPEUTICS

Dewpoint Therapeutics Org Chart and Mapping

Employees

Myrto P

Scientist, Chemistry & Drug Discovery

Holly Abernethy

Global Head People and Culture

Ann Boija

Vice President, Head of Cancer Biology

Sid Beriane

Research Associate II

Thomas Reville

VP, Chemistry, Biophysical Sciences

Miook Cho

Associate Principal Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Dewpoint Therapeutics

Answer: Dewpoint Therapeutics's headquarters are located at 6 Tide St, Boston, Massachusetts, 02210, United States

Answer: Dewpoint Therapeutics's phone number is 61********

Answer: Dewpoint Therapeutics's official website is https://dewpointx.com

Answer: Dewpoint Therapeutics's revenue is $25 Million to $50 Million

Answer: Dewpoint Therapeutics's SIC: 2834

Answer: Dewpoint Therapeutics has 51-200 employees

Answer: Dewpoint Therapeutics is in Biotechnology

Answer: Dewpoint Therapeutics contact info: Phone number: 61******** Website: https://dewpointx.com

Answer: Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has multiple programs across an ambitious pipeline spanning oncology, neurodegeneration, cardiopulmonary, and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck, and Pfizer. Dewpoint scientists work in Boston, Dresden and Frankfurt to translate condensate biology into breakthrough treatments for diseases previously considered untreatable.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access